September 14—Baltimore, Maryland— Scheril Murray Powell, Esq., SMP LAW/Creative Services, will give a keynote talk tomorrow in the hemp room 308 at 2:40 p.m. The talk is titled “Navigating the Evolving Needs of a Global Cannabis Company as In House Counsel.”
Scheril Murray Powell, Esq., SMP LAW/Creative Services, will give a keynote talk tomorrow in the hemp room 308 at 2:40 p.m. The talk is titled “Navigating the Evolving Needs of a Global Cannabis Company as In House Counsel.”
The role of in-house counsel varies in responsibilities, in some companies the focus is on litigation related activities, in others the focus is on compliance and government relations. It is not unusual for the in-house counsel to also work closely with the CEO and HR teams on employee issues. The start-up cannabis company has many needs, but also has evolving needs. The role of in-house counsel may start out in an advisory role to the CEO acting as a Swiss army knife of functionality on any topic that comes up. As the company grows, the needs will change and more narrowly focused, strategic activity for the in-house counsel will. This discussion will cover the varied and evolving in-house counsel role.
Scheril Murray Powell, Esq., is an agricultural, cannabis, and dietary supplement attorney at Doumar, Allsworth, Laystrom, Voigt, Adair, and Dishowitz LLP. Scheril also serves as the Director of Business Development of Creative Services, a FCRA compliance, background screening, and security firm. The Daily Business Review has named her one of the Top 12 cannabis attorney’s in Florida. Her practice covers both the marijuana and hemp industries, specializing in cannabinoid legalization and UK novel foods registration.
For more information on the hemp track, please visit the 2021 Cannabis Science Conference East Final Program & Exhibitor Guide.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.